𝔖 Bobbio Scriptorium

✦ LIBER ✦

Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes

✍ Scribed by Mrinalini Kulkarni; Peter D. Reaven

Book ID: 107535934
Publisher: Current Science Inc.
Year: 2002
Tongue: English
Weight: 172 KB
Volume: 2
Category: Article
ISSN: 1534-4827
DOI: 10.1007/s11892-002-0094-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M.556 LDL-cholesterol levels in patients

M.556 LDL-cholesterol levels in patients with coronary heart disease receiving lipid-lowering therapy: Relation to pretreatment LDL-cholesterol and CHD risk status (reality study, Germany)

✍ Krobot, K.J.; Yin, D.; Alemao, E.; Steinhagen-Thiessen, E. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 139 KB

The effects of lowering LDL cholesterol

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

✍ Colin Baigent; Martin J Landray; Christina Reith; Jonathan Emberson; David C Whe 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 456 KB

The effects of lowering LDL cholesterol

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

✍ Colin Baigent; Martin J Landray; Christina Reith; Jonathan Emberson; David C Whe 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 456 KB

Increased risk for cardiovascular outcom

Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE)

✍ Toshitsugu Ishikawa; Hideki Ito; Yasuyoshi Ouchi; Yasuo Ohashi; Yasushi Saito; H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 982 KB

Trial finds low dose ramipril does not r

Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria: Abstracted from: Marre M, Lievre M, Chatellier G, et al. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004; 328(7438): 495–500.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB